Zobrazeno 1 - 10
of 10
pro vyhledávání: '"J. B. Garris"'
Autor:
L S, Marks, A W, Partin, J I, Epstein, V E, Tyler, I, Simon, M L, Macairan, T L, Chan, F J, Dorey, J B, Garris, R W, Veltri, P B, Santos, K A, Stonebrook, J B, deKernion
Publikováno v:
The Journal of urology. 163(5)
We tested the effects of a saw palmetto herbal blend in men with symptomatic benign prostatic hyperplasia (BPH) via a randomized, placebo controlled trial.We randomized 44 men 45 to 80 years old with symptomatic BPH into a trial of a saw palmetto her
Autor:
L S, Marks, A W, Partin, F J, Dorey, G J, Gormley, J I, Epstein, J B, Garris, M L, Macairan, E D, Shery, P B, Santos, E, Stoner, J B, deKernion
Publikováno v:
Urology. 53(3)
To determine the long-term effects of finasteride treatment on prostate tissue composition; to relate these effects to clinical outcomes; and to test the hypothesis that finasteride exerts a selective or preferential action on the transition zone.Nin
Autor:
L S, Marks, A W, Partin, G J, Gormley, F J, Dorey, E D, Shery, J B, Garris, E N, Subong, E, Stoner, J B, deKernion
Publikováno v:
The Journal of urology. 157(6)
We sought to quantify prostate tissue changes induced by finasteride and to identify a predictor of finasteride response in men with symptomatic benign prostatic hyperplasia (BPH) via a randomized, placebo controlled, double-blind clinical trial.Men
Publikováno v:
Female Pelvic Medicine & Reconstructive Surgery. 16:S28
Autor:
L. S. Marks, A. W. Partin, G. J. Gormley, F. J. Dorey, E. D. Shery, J. B. Garris, E. N. P. Subong, E. Stoner, J. B. deKemion
Publikováno v:
The Journal of Urology. :134
Publikováno v:
Proceedings of the National Academy of Sciences. 86:1382-1386
Recombinant factor VIIa (rF.VIIa) is a two-chain procoagulant enzyme (Mr, approximately 50,000) active only when complexed with tissue factor in the extrinsic clotting system. We administered human rF.VIIa to hemophilic and von Willebrand disease (vW
Publikováno v:
Blood. 66:562-569
An acquired inhibitor of von Willebrand factor (vWF) activity occurring in a patient with benign gammopathy and von Willebrand syndrome (vWS) has been partially characterized. The inhibitor-induced syndrome resulted in low to undetectable plasma leve
Publikováno v:
Radiology. 134:179-183
Two patients with infrahepatic interruption of the inferior vena cava (IVC) with azygos (hemiazygos) continuation were examined ultrasonographically and the findings compared to seven normal studies. Pathognomonic ultrasonographic features of this an
Autor:
Thomas R. Griggs, J B Garris, Marjorie S. Read, Kenneth M. Brinkhous, C Mattsson, M Palm, H Sandberg
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America. 82(24)
The procoagulant protein F.VIII:C is noncovalently bound to von Willebrand factor (vWF) to give the factor VIII macromolecular complex. New highly purified preparations of isolated human F.VIII:C, devoid of vWF and about 500,000-fold purified, were a
Publikováno v:
Laboratory investigation; a journal of technical methods and pathology. 59(4)
Thrombotic thrombocytopenia with severe von Willebrand factor (vWF) depletion was induced in rats by intraperitoneal injection of botrocetin, a Bothrops factor requiring vWF for platelet aggregation. The vWF deficiency state with thrombocytopenia was